WO2020114861A1 - Devices, systems, and methods for simultaneous liquid infusion and catheter motion - Google Patents

Devices, systems, and methods for simultaneous liquid infusion and catheter motion Download PDF

Info

Publication number
WO2020114861A1
WO2020114861A1 PCT/EP2019/082772 EP2019082772W WO2020114861A1 WO 2020114861 A1 WO2020114861 A1 WO 2020114861A1 EP 2019082772 W EP2019082772 W EP 2019082772W WO 2020114861 A1 WO2020114861 A1 WO 2020114861A1
Authority
WO
WIPO (PCT)
Prior art keywords
liquid
vascular treatment
actuator
actuatable
actuation device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2019/082772
Other languages
English (en)
French (fr)
Inventor
Adam Tschida
James David CEZO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Koninklijke Philips NV
Original Assignee
Koninklijke Philips NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Philips NV filed Critical Koninklijke Philips NV
Priority to JP2021530240A priority Critical patent/JP7428711B2/ja
Priority to EP19813272.2A priority patent/EP3886746A1/en
Priority to US17/298,780 priority patent/US20220031393A1/en
Priority to CN201980087702.9A priority patent/CN113260330A/zh
Publication of WO2020114861A1 publication Critical patent/WO2020114861A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/20Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser
    • A61B18/22Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor
    • A61B18/24Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using laser the beam being directed along or through a flexible conduit, e.g. an optical fibre; Couplings or hand-pieces therefor with a catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00166Multiple lumina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2218/00Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2218/001Details of surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body having means for irrigation and/or aspiration of substances to and/or from the surgical site
    • A61B2218/002Irrigation

Definitions

  • the devices, systems, and methods described herein generally relate to vascular surgical procedures that include liquid infusion and catheter use, and more specifically relate to surgical procedures that include simultaneous liquid infusion to a patient and catheter motion within the patient.
  • Some surgical procedures include simultaneous liquid infusion to a patient and catheter translation within the patient.
  • laser atherectomy procedures typically involve simultaneous saline infusion to a patient and laser catheter translation within the patient.
  • these procedures involve actuating a syringe carrying a liquid while advancing the catheter within the patient.
  • a single user for example, a surgeon
  • a single user typically actuates the syringe while a second user (for example, a second surgeon) advances the catheter within the patient.
  • this approach requires considerable coordination and communication between the users to ensure that liquid delivery and catheter translation occur at appropriate rates.
  • syringe actuation relies on the ability of the user to apply sufficient pressure to generate an appropriate flow rate. If the viscosity of the liquid is relatively high and/or the liquid is delivered via a relatively narrow passageway (for example, between the catheter and an introducer through which the catheter extends), the resulting pressure can be too great for the user to reach the desired flow rate using a syringe. In these situations, user typically turns to a powered infusion system. However, such infusion systems are not available in all settings and are typically viewed as being cost prohibitive.
  • the present disclosure presents a vascular treatment system that includes a vascular treatment device configured to be disposed within a treatment space of a subject.
  • the system further includes an actuation device operatively coupled to the vascular treatment device.
  • the actuation device includes a movement actuator operatively coupled to the vascular treatment device.
  • the movement actuator is actuatable to move the vascular treatment device within the treatment space.
  • the actuation device further includes a liquid reservoir carrying a liquid, and a liquid infusion actuator operatively coupled to the liquid reservoir.
  • the liquid infusion actuator is actuatable to deliver the liquid from the liquid reservoir to the treatment space via the vascular treatment device.
  • the device further includes a user input actuatable to simultaneously actuate the movement actuator and the liquid infusion actuator.
  • the vascular treatment device includes an introducer sheath having an inner lumen, and a catheter translatably carried in the inner lumen of the introducer sheath.
  • the catheter includes a distal end configured to be disposed in the treatment space
  • the actuation device further includes an indicator configured to indicate a position of the distal end of the catheter relative to the actuation device.
  • the actuation device further includes a housing, the user input is a trigger, and the trigger is translatably actuatable relative to the housing to simultaneously actuate the movement actuator and the liquid infusion actuator.
  • the movement actuator includes an arm coupling the trigger to the vascular treatment device.
  • the actuation device further includes a housing, the user input is a lever, and the lever is rotatably actuatable relative to the housing to simultaneously actuate the movement actuator and the liquid infusion actuator.
  • the present disclosure presents an actuation device for a vascular treatment system.
  • the actuation device includes a movement actuator configured to be operatively coupled to a vascular treatment device.
  • the movement actuator is actuatable to move the vascular treatment device within a treatment space of a subject.
  • the actuation device further includes a liquid reservoir carrying a liquid, and a liquid infusion actuator operatively coupled to the liquid reservoir.
  • the liquid infusion actuator is actuatable to deliver the liquid from the liquid reservoir to the treatment space via the vascular treatment device.
  • the actuation device further includes a user input actuatable to simultaneously actuate the movement actuator and the liquid infusion actuator.
  • the device according to the previous paragraph further including an indicator configured to indicate a position of the vascular treatment device relative to the actuation device.
  • the device further including a housing, wherein the user input is a trigger, and the trigger is translatably actuatable relative to the housing to
  • the movement actuator includes an arm configured to couple the trigger to the vascular treatment device.
  • the device further including a housing, wherein the user input is a lever, and the lever is rotatably actuatable relative to the housing to simultaneously actuate the movement actuator and the liquid infusion actuator.
  • the liquid reservoir includes a syringe chamber carrying the liquid
  • the liquid infusion actuator includes a piston movably carried within the syringe chamber.
  • the present disclosure presents a vascular treatment system including a vascular treatment device configured to be disposed within a treatment space of a subject.
  • the system further includes an actuation device operatively coupled to the vascular treatment device.
  • the actuation device includes a movement actuator operatively coupled to the vascular treatment device.
  • the movement actuator is actuatable to move the vascular treatment device within the treatment space.
  • the actuation device further includes a liquid infusion actuator configured to operatively couple to a liquid reservoir.
  • the liquid infusion actuator is actuatable to deliver a liquid from the liquid reservoir to the treatment space via the vascular treatment device.
  • the actuation device further includes a user input being actuatable to simultaneously actuate the movement actuator and the liquid infusion actuator.
  • the present disclosure presents an actuation device for a vascular treatment system, and the actuation device includes a movement actuator configured to be operatively coupled to a vascular treatment device.
  • the movement actuator is actuatable to move the vascular treatment device within a treatment space of a subject.
  • the actuation device further includes a liquid infusion actuator configured to operatively couple to a liquid reservoir.
  • the liquid infusion actuator is actuatable to deliver a liquid from the liquid reservoir to the treatment space via the vascular treatment device.
  • the actuation device further includes a user input being actuatable to simultaneously actuate the movement actuator and the liquid infusion actuator.
  • phrases“at least one”,“one or more”, and“and/or” are open-ended expressions that are both conjunctive and disjunctive in operation.
  • A, B, and/or C means A alone, B alone, C alone, A and B together, A and C together, B and C together, or A, B and C together.
  • an element such as X, Y, and Z, or class of elements, such as Xi-X n , Y i-Y m , and Zi-Z 0
  • the phrase is intended to refer to a single element selected from X, Y, and Z, a combination of elements selected from the same class (for example, Xi and X2) as well as a combination of elements selected from two or more classes (for example, Y 1 and Z 0 ).
  • the term“a” or“an” entity refers to one or more of that entity.
  • the terms“a” (or “an”),“one or more” and“at least one” may be used interchangeably herein.
  • the terms“comprising”,“including”, and“having” may be used interchangeably.
  • FIG. 1 is a schematic illustration of a vascular treatment system according to an embodiment of the present disclosure.
  • FIG. 2 is a perspective partial view of an exemplary vascular treatment device of vascular treatment systems according to embodiments of the present disclosure.
  • FIG. 3 is a perspective partial view of another exemplary vascular treatment device of vascular treatment systems according to embodiments of the present disclosure.
  • FIG. 4 is a side view of an exemplary actuation device of vascular treatment systems according to embodiments of the present disclosure.
  • FIG. 5A is a longitudinal sectional view of another exemplary actuation device of vascular treatment systems according to embodiments of the present disclosure.
  • FIG. 5B is a side view of the actuation device of FIG. 5A.
  • FIG. 6A is a side view of another exemplary actuation device of vascular treatment systems according to embodiments of the present disclosure.
  • FIG. 6B is a perspective view of a syringe chamber, a piston, a trigger, and an arm of the actuation device of FIG. 6A.
  • FIG. 7 is a perspective view of yet another exemplary actuation device of vascular treatment systems according to embodiments of the present disclosure.
  • FIG. 1 illustrates a vascular treatment system 100 according to an embodiment of the present disclosure.
  • the vascular treatment system 100 generally includes a vascular treatment device 102 that is configured to be disposed within a treatment space and provide treatment to a subject during a vascular surgical procedure.
  • the vascular treatment device 102 is operatively coupled to an actuation device 104 that is configured to be disposed externally to the subject and manipulated by a user (for example, a surgeon).
  • the actuation device 104 includes a movement actuator 106 that is operatively coupled to and facilitates movement of the vascular treatment device 102 within the treatment space.
  • the actuation device 104 also includes a liquid reservoir 108 and a liquid infusion actuator 110 that are operatively coupled to the vascular treatment device 102 and facilitate delivery of a liquid to the treatment space via the vascular treatment device 102.
  • the actuation device 104 includes a user input 112 that may be actuated by a user to facilitate simultaneous actuation of the movement actuator 106 and the liquid infusion actuator 110, and the actuation device 104 thereby moves the vascular treatment device 102 within the treatment space and delivers a liquid to the treatment space via the vascular treatment device 102. Detailed examples of the above components are described below.
  • Vascular treatment devices forming part of systems according to embodiments of the present disclosure may take various forms. Generally, vascular treatment devices according to some
  • embodiments of the present disclosure include an introducer or delivery sheath, a treatment catheter that is translatably carried within and extendable from the introducer sheath, and a guidewire.
  • an exemplary embodiment of a vascular treatment device 200 is illustrated.
  • the vascular treatment device 200 includes an introducer or delivery sheath 202, a laser catheter 204 that is translatably received within a lumen 206 of the introducer sheath 202 and extendable from a distal end 208 of the introducer sheath 202, and a guidewire 210 that is translatably received within a lumen 212 of the laser catheter 204 and along which the laser catheter 204 translates to reach the treatment space.
  • the laser catheter 204 couples to a laser generator (not shown - such as, for example, the Spectranetics CVX-300 ® Excimer Laser System, which is available from the Koninklijke Philips N.V.), receives laser energy therefrom, and emits the laser energy to treat tissue and/or other materials (for example, an occlusion) within the treatment space of the subject.
  • a laser generator not shown - such as, for example, the Spectranetics CVX-300 ® Excimer Laser System, which is available from the Koninklijke Philips N.V.
  • receives laser energy therefrom receives laser energy therefrom, and emits the laser energy to treat tissue and/or other materials (for example, an occlusion) within the treatment space of the subject.
  • the laser catheter 204 may be or may be similar to, for example, any Spectranetics laser catheters available from Koninklijke Philips N.V.
  • Such laser catheters include, for example, those available under the tradenames ELCATM and Turbo EliteTM (each of which is used for coronary intervention or peripheral intervention, respectively, such as recanalizing occluded arteries, changing lesion morphology, and facilitating stent placement) and SLSIITM and GlideLightTM (which is used for surgically implanted lead removal).
  • the working (distal) end 214 of the laser catheter 204 may have a plurality of laser emitters 216 (for example, optical fibers) that emit the laser energy received from the laser generator and ablate the targeted tissue and/or other materials within the treatment space.
  • the opposite (proximal) end of the laser catheter 204 may have a fiber optic coupler (not shown) for coupling the laser catheter 204 to the laser generator.
  • the liquid carried in the liquid reservoir and delivered to the treatment space may be saline.
  • the liquid reservoir may be in fluid communication with the lumen 206 of the introducer sheath 202, and the liquid reservoir may deliver the liquid to the treatment space via the lumen 206 of the introducer sheath 202.
  • FIG. 3 illustrates another specific exemplary embodiment of a vascular treatment device 300.
  • the vascular treatment device 300 includes an introducer or delivery sheath 302, a laser catheter 304 that is translatably carried within a lumen 306 of the introducer sheath 302 and extendable from a distal end 308 of the introducer sheath 302, and a guidewire 310 that is translatably received within a lumen 312 of the laser catheter 304 and along which the laser catheter 304 translates to reach the treatment space.
  • the introducer sheath 302 may be or may be similar to, for example, any of the introducer sheaths (also referred to as“outer sheaths”) described in the patent documents listed below.
  • the laser catheter 304 may be or may be similar to, for example, any of the laser catheters described in the patent documents listed below.
  • the introducer sheath 302, the laser catheter 304, and the guidewire 310 may generally be used to facilitate treatment within a treatment space in the same or similar manners to any of those described in the patent documents listed below (particularly, to emit laser energy into contrast solution to thereby generate pressure waves P for disrupting vascular occlusions, fracturing intraluminal calcium deposits, and/or fracturing medial calcium deposits).
  • the liquid carried in the liquid reservoir and delivered to the treatment space may be contrast medium or contrast solution, as described in the patent documents listed below.
  • the liquid reservoir may be in fluid communication with the lumen 306 of the introducer sheath 302, and the liquid reservoir may deliver the liquid to the treatment space via the lumen 306 of the introducer sheath 302.
  • the following patent documents are hereby incorporated herein by reference in their entireties for all that they teach and for all purposes: U.S. Application Ser. No. 14/984,308, fded December 30, 2015, entitled Laser-Induced Pressure Wave Emitting Catheter Sheath; U.S. Application Ser. No. 14/984,050, fded December 30, 2015, entitled Laser- Induced Fluid Filled Balloon Catheter; U.S. Application Ser. No.
  • actuation devices facilitate simultaneous movement of the vascular treatment device within the treatment space and delivery of a liquid to the treatment space via the vascular treatment device.
  • Such actuation devices may take various forms.
  • FIG. 4 an exemplary embodiment of an actuation device 400 is illustrated.
  • the actuation device 400 includes a housing 402 that is configured to be grasped by a user during a vascular surgical procedure.
  • the housing 402 couples to an introducer sheath 404 at a first end 406.
  • the introducer sheath 404 translatably carries a catheter (shown elsewhere), and the catheter extends through the housing 402 and outwardly from a port 408 at a second end 410 (for example, to facilitate coupling the catheter to a laser generator).
  • the housing 402 translatably carries a movement actuator, more specifically an arm 412, that is coupled to the catheter within the housing 402.
  • the housing 402 further carries a liquid reservoir, more specifically a syringe chamber 414, that carries a liquid and is in fluid communication with the introducer sheath 404.
  • the syringe chamber 414 translatably carries a liquid infusion actuator, more specifically a piston 416.
  • the piston 416 and the arm 412 both couple to a user input, more specifically a trigger 418, that is actuated by translating toward the second end 410 of the housing 402.
  • actuation of the trigger 418 causes simultaneous movement of the catheter relative to the introducer sheath 404 within the treatment space (specifically, proximally relative to the introducer sheath 404) and delivery of the liquid from the syringe chamber 414 to the treatment space via the introducer sheath 404.
  • the actuation device 400 includes an indicator for indicating the position of the distal end of the catheter.
  • the indicator may include an opening 420 that shows the position of the arm 412 within the housing 402 and relative to a plurality of demarcations 422.
  • the housing 402 may be shaped and the trigger 418 and the syringe chamber 414 may be positioned such that the actuation device 400 generally has a pistol-like appearance.
  • FIGS. 5A and 5B illustrate another specific exemplary embodiment of an actuation device 500.
  • the actuation device 500 includes a housing 502 that is configured to be grasped by a user during a vascular surgical procedure.
  • the housing 502 couples to an introducer sheath (shown elsewhere) at a first end 504.
  • the introducer sheath translatably carries a catheter (shown elsewhere), and the catheter extends through the housing 502 and outwardly from a port at a second end 508 (for example, to facilitate coupling the catheter to a laser generator).
  • the housing 502 translatably carries a movement actuator, more specifically an arm (not shown), that is coupled to the catheter within the housing 502.
  • the housing 502 further carries a liquid reservoir, more specifically a syringe chamber 510, that carries a liquid and is in fluid communication with the introducer sheath.
  • the syringe chamber 510 translatably carries a liquid infusion actuator, more specifically a piston 512.
  • the piston 512 and the arm both couple to a user input, more specifically a trigger 514, that is actuated by translating toward the second end 508 of the housing 502.
  • actuation of the trigger 514 causes simultaneous movement of the catheter relative to the introducer sheath within the treatment space (specifically, proximally relative to the introducer sheath) and delivery of the liquid from the syringe chamber 510 to the treatment space via the introducer sheath.
  • the housing 502 may be shaped such that the actuation device 500 generally has an elongated syringe-like appearance.
  • FIGS. 6A and 6B illustrate another specific exemplary embodiment of an actuation device 600.
  • the actuation device 600 includes a housing 602 that is configured to be grasped by a user during a vascular surgical procedure.
  • the housing 602 couples to an introducer sheath 604 at a first end 606.
  • the introducer sheath 604 translatably carries a catheter 608, and the catheter 608 extends through the housing 602 and outwardly from a port 610 at a second end 612 (for example, to facilitate coupling the catheter 608 to a laser generator).
  • the housing 602 translatably carries a movement actuator, more specifically an arm 614 (see FIG. 6B), that is coupled to the catheter 608 within the housing 602.
  • the housing 602 further carries a liquid reservoir, more specifically a syringe chamber 616, that carries a liquid and is in fluid communication with the introducer sheath 604.
  • the syringe chamber 616 translatably carries a liquid infusion actuator, more specifically a piston 618.
  • the piston 618 and the arm 614 both couple to a user input, more specifically a trigger 620, that is actuated by translating toward the second end 612 of the housing 602.
  • the actuation device 600 includes an indicator for indicating the position of the distal end of the catheter 608.
  • the indicator may include an opening 622 that shows the position of the trigger 620 relative to a plurality of demarcations 624 and indicia 626.
  • the housing 602 may be shaped such that the actuation device 600 generally has an elongated syringe-like appearance.
  • FIG. 7 illustrates another specific exemplary embodiment of an actuation device 700.
  • the actuation device 700 includes a housing 702 that is configured to be grasped by a user during a vascular surgical procedure.
  • the housing 702 couples to an introducer sheath 704 at a first end 706.
  • the introducer sheath 704 translatably carries a catheter 708, and the catheter 708 extends through the housing 702 and outwardly from a port 710 at a second end 712 (for example, to facilitate coupling the catheter 708 to a laser generator).
  • the housing 702 carries a user input, specifically a rotatable lever 714.
  • the lever 714 carries a liquid reservoir, more specifically a syringe chamber 716, that carries a liquid and is in fluid communication with the introducer sheath 704.
  • the syringe chamber 716 translatably carries a liquid infusion actuator, more specifically a piston 718.
  • the housing 702 translatably carries a movement actuator, more specifically an arm (not shown), that is coupled to the lever 714 and the catheter 708 within the housing 702.
  • actuation of the lever 714 causes simultaneous movement of the catheter 708 relative to the introducer sheath 704 within the treatment space (specifically, proximally relative to the introducer sheath 704) and delivery of the liquid from the syringe chamber 716 to the treatment space via the introducer sheath 704.
  • the actuation device 700 could include a ratcheting mechanism (not shown) where the piston 718 is advanced toward the hinge of the lever 714 by a certain distance with each actuation of the lever 714. This action would pressurize the liquid in the syringe chamber 716 and thereby deliver the liquid to the catheter.
  • the orientation of the piston 718 and the syringe chamber 716 could be inverted, and the piston 718 could be directly linked into the hinge of the lever 714 and arranged to be pushed or pulled with each actuation of the lever 714.
  • the piston 718 and the syringe chamber 716 could be disposed within the housing 702, and the lever 714 could be arranged to act upon the piston 718 by converting rotation of the lever 714 to a linear incremental motion (for example, by a rack and pinion; not shown) and indexed to only advance in one direction.
  • the chamber 716 could be compliant or compressible such that mechanical pressure exerted on the chamber 716 would pressurize the liquid.
  • the lever 714 couples to an off-hinge linking arm (not shown), which linearly actuates the piston 718 upon rotation of the lever 714.
  • the piston 718 may thereby deliver a pressurized fluid (for example, air) to an actuation chamber (not shown) via a one-way pressure valve (not shown).
  • the actuation chamber may thereby expand, engage the chamber 716, and cause the chamber 716 to deliver the liquid to the catheter.
  • certain features of the systems and devices described herein may be designed to facilitate delivering liquid at an appropriate flow rate relative to a catheter’s translation rate.
  • diameters of a syringe chamber and a piston may be selected to facilitate delivering liquid at an appropriate flow rate relative to a catheter’s translation rate.
  • the liquid delivery rate is fixed relative to a catheter’s translation rate. In other embodiments, the liquid delivery rate may be variable relative to a catheter’s translation rate.
  • catheters advance proximally upon actuation of actuation devices. In other embodiments, catheters advance distally upon actuation of actuation devices.
  • liquid reservoirs are carried by actuation devices.
  • liquid reservoirs deliver liquids to actuation devices but are not carried by, or are disposed externally from, actuation devices.
  • actuation devices may include valves to facilitate coupling to liquid reservoirs, and liquid reservoirs could be pressurized.
  • systems and devices include and/or are used together with laser catheters. In other embodiments, systems and devices according to the present disclosure may include and/or may be used together with other types of catheters.
  • such catheters could emit other types of electromagnetic energy (for example, radio-frequency energy) to treat tissues and/or other materials within a treatment space, or such catheters could operate without emitting electromagnetic energy to treat tissues and/or other materials within a treatment space.
  • some catheters could include cutting elements that physically engage and treats tissue and/or other materials in the treatment space.
  • systems and devices according to the present disclosure may include and/or may be used together with rotational atherectomy catheters.
  • systems and devices according to the present disclosure may include and/or may be used together with orbital atherectomy catheters.
  • systems and devices according to the present disclosure may include and/or may be used together with intravascular imaging catheters.
  • systems and devices according to the present disclosure may include and/or may be used together with catheters in which a portion or all of a catheter tip or body can rotate relative to other portions of a catheter and/or an introducer or delivery sheath; in these embodiments, the liquid may be a lubricant that facilitates rotation of the catheter.
  • movement actuators of systems and devices according to embodiments of the present disclosure may include transmissions or speed reducers.
  • a user input may be a wheel that is rotatably carried by a housing of the actuation device, and the wheel may be rotatably actuatable relative to the housing to simultaneously actuate the movement actuator and the liquid infusion actuator.
  • systems and devices according to the present disclosure may include a chamber (not shown) that is configured such that actuation of the user input produces a negative pressure in the chamber that facilitates aspiration of fluid/materials from the subject.
  • systems, devices, and methods according to the present disclosure can incorporate sealing control devices and methods such as those described in U.S. Application Ser. No. 62/728,004, filed September 6, 2018, entitled Valved Handle Assembly Having a Movable Ring, which is hereby incorporated herein by reference in its entirety for all that it teaches and for all purposes.
  • systems and devices according to the present disclosure are generally mechanical. In other embodiments, systems and devices according to the present disclosure may be electromechanical. More specifically, systems and devices according to the present disclosure may include one or more components that are electrically coupled or non-mechanically operatively coupled to each other.
  • systems according to the present disclosure can be provided to a user (for example, a surgeon) in a“ready to use” configuration (that is, without requiring assembly on the part of the user), such as the system 100 shown in FIG. 1.
  • systems according to the present disclosure can be provided to a user in a disassembled configuration, for example, to permit the user to couple an actuation device to an appropriate vascular treatment device for a particular subject and/or procedure.

Landscapes

  • Health & Medical Sciences (AREA)
  • Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Electromagnetism (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Surgical Instruments (AREA)
PCT/EP2019/082772 2018-12-02 2019-11-27 Devices, systems, and methods for simultaneous liquid infusion and catheter motion Ceased WO2020114861A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2021530240A JP7428711B2 (ja) 2018-12-02 2019-11-27 同時の液体注入及びカテーテル動作のための装置、システム、及び方法
EP19813272.2A EP3886746A1 (en) 2018-12-02 2019-11-27 Devices, systems, and methods for simultaneous liquid infusion and catheter motion
US17/298,780 US20220031393A1 (en) 2018-12-02 2019-11-27 Devices, systems, and methods for simultaneous liquid infusion and catheter motion
CN201980087702.9A CN113260330A (zh) 2018-12-02 2019-11-27 用于同时进行液体输注和导管运动的装置、系统和方法

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862774274P 2018-12-02 2018-12-02
US62/774,274 2018-12-02

Publications (1)

Publication Number Publication Date
WO2020114861A1 true WO2020114861A1 (en) 2020-06-11

Family

ID=68762714

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2019/082772 Ceased WO2020114861A1 (en) 2018-12-02 2019-11-27 Devices, systems, and methods for simultaneous liquid infusion and catheter motion

Country Status (5)

Country Link
US (1) US20220031393A1 (https=)
EP (1) EP3886746A1 (https=)
JP (1) JP7428711B2 (https=)
CN (1) CN113260330A (https=)
WO (1) WO2020114861A1 (https=)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0125843A2 (en) * 1983-05-03 1984-11-21 Catheter Technology Corporation Apparatus for inserting a catheter
US20080009875A1 (en) * 2006-07-07 2008-01-10 Meera Sankaran Medical device with dual expansion mechanism
WO2011008922A2 (en) * 2009-07-16 2011-01-20 Hansen Medical, Inc. Endoscopic robotic catheter system
US20180008348A1 (en) * 2014-08-25 2018-01-11 The Spectranetics Corporation Liquid laser-induced pressure wave emitting catheter sheath
US20180250015A1 (en) * 2016-05-04 2018-09-06 Renalpro Medical, Inc. Devices and Methods for Treating Acute Kidney Injury

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6197001B1 (en) * 1996-09-27 2001-03-06 Becton Dickinson And Company Vascular access device
US20150025500A1 (en) * 2013-03-15 2015-01-22 North Carolina State University Apparatus and method for intraosseous fluid infusion

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0125843A2 (en) * 1983-05-03 1984-11-21 Catheter Technology Corporation Apparatus for inserting a catheter
US20080009875A1 (en) * 2006-07-07 2008-01-10 Meera Sankaran Medical device with dual expansion mechanism
WO2011008922A2 (en) * 2009-07-16 2011-01-20 Hansen Medical, Inc. Endoscopic robotic catheter system
US20180008348A1 (en) * 2014-08-25 2018-01-11 The Spectranetics Corporation Liquid laser-induced pressure wave emitting catheter sheath
US20180250015A1 (en) * 2016-05-04 2018-09-06 Renalpro Medical, Inc. Devices and Methods for Treating Acute Kidney Injury

Also Published As

Publication number Publication date
JP2022510230A (ja) 2022-01-26
JP7428711B2 (ja) 2024-02-06
US20220031393A1 (en) 2022-02-03
CN113260330A (zh) 2021-08-13
EP3886746A1 (en) 2021-10-06

Similar Documents

Publication Publication Date Title
US5785675A (en) Thrombectomy device
JP6968146B2 (ja) 液体レーザ誘起圧力波を放射するカテーテルシース
EP3833289B1 (en) Treatment mode selection systems and laser catheter systems including same
EP3240600B1 (en) Electrically-induced pressure wave emitting catheter sheath
JP4326942B2 (ja) 液体量を制御しつつ局所的な灌注及び吸引を行うための液体交換システム
EP3522812B1 (en) Laser-induced pressure wave emitting catheter sheath
US6135977A (en) Rheolytic catheter
US8133214B2 (en) Material removal catheter and method
EP4192552A1 (en) Automatically-locking vacuum syringes, and associated systems and methods
EP0489496B1 (en) Water jet atherectomy device
EP0485133A1 (en) Asymmetric water jet atherectomy
JP7607082B2 (ja) 医療デバイス
JP2019521802A5 (https=)
US12402907B2 (en) Cutting balloon catheter with concealed blades
CN114601558A (zh) 一种变光纤螺旋角度的激光消融导管
US20220031393A1 (en) Devices, systems, and methods for simultaneous liquid infusion and catheter motion
CN115998377A (zh) 一种切除装置
CN211796844U (zh) 具有激光粉碎血栓功能的智能装置
Sakes et al. Crossing total occlusions using a hydraulic pressure wave: development of the wave catheter
CN115998376A (zh) 一种切除装置
CN221787839U (zh) 导引抽吸导管及具有该导管的导管系统
CN113303904B (zh) 具有激光粉碎血栓功能的智能装置
CN116211410A (zh) 一种切除装置
AU5361200A (en) Thrombectomy method and device
AU7179900A (en) Water jet atherectomy

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19813272

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2021530240

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2019813272

Country of ref document: EP